Eledon Pharmaceuticals
ELDN
ELDN
83 hedge funds and large institutions have $94.5M invested in Eledon Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
7.3% less ownership
Funds ownership: 68.21% → 60.9% (-7.3%)
15% less capital invested
Capital invested by funds: $111M → $94.5M (-$16.2M)
99% less call options, than puts
Call options by funds: $16K | Put options by funds: $1.37M
Holders
83
Holding in Top 10
1
Calls
$16K
Puts
$1.37M
Top Buyers
| 1 | +$3.58M | |
| 2 | +$3.33M | |
| 3 | +$2.75M | |
| 4 |
ZP
Zimmer Partners
New York
|
+$2.19M |
| 5 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$1.9M |
Top Sellers
| 1 | -$7.05M | |
| 2 | -$2.98M | |
| 3 | -$2.71M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.71M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.56M |
